Computer-aided drug design: The next twenty-five years

CINF 15

John Van Drie, johnvandrie@mindspring.com, Novartis Institutes for Biomedical Research, 250 Mass AVe, Cambrige, MA 02139
In a somewhat-serious, somewhat-lighthearted way, prognostications will be made on what the future holds for our field. Drawing upon the past, and in particular on the many roles that Yvonne Martin has played in that past, some possible future evolutionary paths of this field will be sketched. The areas for greatest potential impact on drug discovery and design will be highlighted. Also, today's key outstanding issues will be framed, to draw attention to these issues for students and others new to this field, in the hope that they will be the biggest determinant of what the future holds for CADD.